Aspirin Desensitization in the Treatment of Antiphospholipid Syndrome during Pregnancy in ASA‐sensitive Patients

Abstract

Aspirin desensitization may be a safe alternative even during pregnancy if carefully monitored and permit patients with APS to receive treatment with ASA. This would constitute a new indication in pregnant women with APS and ASA sensitivity.